1. Home
  2. AWRE vs INTS Comparison

AWRE vs INTS Comparison

Compare AWRE & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AWRE
  • INTS
  • Stock Information
  • Founded
  • AWRE 1986
  • INTS 2012
  • Country
  • AWRE United States
  • INTS United States
  • Employees
  • AWRE N/A
  • INTS N/A
  • Industry
  • AWRE Computer Software: Prepackaged Software
  • INTS Biotechnology: Pharmaceutical Preparations
  • Sector
  • AWRE Technology
  • INTS Health Care
  • Exchange
  • AWRE Nasdaq
  • INTS Nasdaq
  • Market Cap
  • AWRE 35.2M
  • INTS 33.4M
  • IPO Year
  • AWRE 1996
  • INTS 2023
  • Fundamental
  • Price
  • AWRE $1.70
  • INTS $2.20
  • Analyst Decision
  • AWRE
  • INTS Strong Buy
  • Analyst Count
  • AWRE 0
  • INTS 3
  • Target Price
  • AWRE N/A
  • INTS $8.50
  • AVG Volume (30 Days)
  • AWRE 43.2K
  • INTS 40.1K
  • Earning Date
  • AWRE 03-11-2025
  • INTS 03-13-2025
  • Dividend Yield
  • AWRE N/A
  • INTS N/A
  • EPS Growth
  • AWRE N/A
  • INTS N/A
  • EPS
  • AWRE N/A
  • INTS N/A
  • Revenue
  • AWRE $16,966,000.00
  • INTS N/A
  • Revenue This Year
  • AWRE $10.98
  • INTS N/A
  • Revenue Next Year
  • AWRE N/A
  • INTS N/A
  • P/E Ratio
  • AWRE N/A
  • INTS N/A
  • Revenue Growth
  • AWRE N/A
  • INTS N/A
  • 52 Week Low
  • AWRE $1.35
  • INTS $1.50
  • 52 Week High
  • AWRE $2.97
  • INTS $5.94
  • Technical
  • Relative Strength Index (RSI)
  • AWRE 56.48
  • INTS 54.20
  • Support Level
  • AWRE $1.60
  • INTS $2.00
  • Resistance Level
  • AWRE $1.75
  • INTS $2.37
  • Average True Range (ATR)
  • AWRE 0.10
  • INTS 0.31
  • MACD
  • AWRE 0.01
  • INTS -0.00
  • Stochastic Oscillator
  • AWRE 86.36
  • INTS 48.24

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with major unmet medical need.

Share on Social Networks: